Thrombosis
News
Health Canada approves drug for patients with VTE, NVAF
Image by Andre E.X.
News
Generic bivalirudin available in US
Photo from Business Wire Fresenius Kabi’s Bivalirudin for Injection, a generic alternative to The Medicines Company’s Angiomax, is now available...
News
Testing could ID cancer patients at high risk of VTE
Image by Andre E.X.
News
Tranexamic acid safely reduces need for transfusion, study suggests
Photo by Piotr Bodzek Results of a large study suggest that tranexamic acid can reduce the need for blood transfusion without increasing the risk...
News
Drug approved to treat hemophilia B in Switzerland
Photo courtesy of Biogen The Swiss Agency for Therapeutic Products, Swissmedic, has approved eftrenonacog alfa (Alprolix®) for the treatment of...
News
Agent could treat hemophilia A and B, team says
A new bypassing agent mimics the pro-clotting activity of factor V Leiden and might prove effective for treating hemophilia A and B, according to...
News
Resource use lower for patients on dabigatran, data suggest
Photo by ec-jpr Real-world data suggest that, in the first year of treatment with an anticoagulant, patients with non-valvular atrial...
News
Drug fails to meet endpoint in phase 3 ITP trial
The SYK inhibitor fostamatinib did not meet the primary endpoint in a phase 3 study of adults with chronic/persistent immune thrombocytopenia (ITP...
News
Work reveals potential therapeutic targets in AML
By adapting CRISPR-Cas9 technology and using it to screen the leukemia genome, researchers have identified hundreds of potential therapeutic...
News
Gene therapy could treat hemophilia A
A new discovery contradicts prevailing assumptions about hemophilia and could change the treatment of hemophilia A, according to researchers. The...
News
Trial of hemophilia therapy back on
Image courtesy of NIGMS A UK regulatory agency has lifted the hold placed on a phase 1/2 study of the gene therapy BMN 270 in patients with...